Surveys

C. difficile Survey (CLOSED)

SURVEY CLOSED The Gastrointestinal Society represents patients with gastrointestinal diseases and disorders on a variety of health care fronts. We have designed this survey to help us understand your opinions and outlook regarding the effects that infection with the C. difficile bacterium has on the lives of patients. We will use this information anonymously and [...]

By |2016-11-23T11:29:11-07:00March 8, 2016|News, Surveys|

Survey Results: Biosimilars

  The Gastrointestinal Society represents inflammatory bowel disease (IBD) patients on a variety of health care fronts, including access to medications. During the first part of 2015, we hosted a survey on our English (www.badgut.org) & French (www.mauxdeventre.org) websites to help understand IBD patients’ opinions and outlooks regarding biosimilars (subsequent entry biologics/SEBs). To qualify, survey [...]

By |2017-07-28T13:36:34-07:00July 30, 2015|News, Surveys|

Call for Patient Perspectives: Canadians with IBD

Attention Canadian patients who have inflammatory bowel disease (IBD): Crohn’s disease and ulcerative colitis. THIS SURVEY IS CLOSED Janssen Canada has engaged a third party to conduct a survey to learn about your opinions and experiences regarding therapies for IBD. They will use the data in aggregate and Janssen will not receive any of your [...]

By |2016-02-19T10:30:29-07:00July 23, 2015|News, Surveys|

Call for Patient Perspectives – Constella® for Chronic Constipation

The Gastrointestinal Society is looking for details of patients’ experiences using Constella®. We invite Canadians with a history of chronic constipation who have used Constella® (linaclotide) to complete this brief survey. We will use this information in aggregate as the GI Society advocates on behalf of patients with this condition.   Why? The GI Society [...]

By |2016-02-10T08:08:09-07:00November 12, 2014|Surveys|

Call for Patient Perspectives – Ulcerative Colitis

THIS SURVEY IS NOW CLOSED The Gastrointestinal Society is looking for details of Canadian patients’ experiences with ulcerative colitis (UC). We will use this information in aggregate in our patient advocacy activities, including patient group submissions for drug coverage, public awareness campaigns, and other relevant initiatives. The GI Society is a trusted, long-standing, national charity [...]

By |2016-02-19T10:21:06-07:00July 17, 2014|Surveys|

Call for Patient Perspectives – PPIs (Quebec Only)

Have you been forced to switch your medication? As of October 1, 2013, the maximum reimbursement allowed by the Medical Insurance Public Regime of Quebec for PPIs is capped at 0.55$ per tablet. As many as 200,000 patients who suffer from severe heartburn (GERD) could face a medication substitution in order to avoid having to [...]

By |2016-02-19T10:13:33-07:00July 15, 2014|Surveys|